Saltar al contenido
Nutrición y metabolismoEnsayo aleatorizado4 min read

After diet weight loss, exercise improved fitness; liraglutide alone did not

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity. · Sports medicine (Auckland, N.Z.) · 2026 · Artículo original ↗

Idea principal

In 193 adults with obesity who had lost weight on a low-calorie diet, exercise plus liraglutide cut stair-climb time by 1.2 s and raised peak oxygen uptake by 3.0 mL/min/kg fat-free mass versus liraglutide alone, and exercise alone gave similar gains. This is a secondary analysis of key secondary endpoints, so it was not the trial's main question.

Study design

Ensayo aleatorizado

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Obesity impairs physical fitness, which affects quality of life and survival, and weight-loss drugs may not fix that. The authors tested whether a moderate-to-vigorous exercise program, the GLP-1 receptor agonist liraglutide, or both, would improve physical function, cardiorespiratory fitness and muscle strength during the year after diet-induced weight loss.

Población y método

Secondary analysis of a randomized controlled trial in 193 adults with obesity (age 18-65 years, body mass index 32-43 kg/m2) without diabetes. After an 8-week low-calorie diet, participants were randomized 1:1:1:1 to exercise plus placebo, liraglutide 3 mg once daily plus usual activity, exercise plus liraglutide, or placebo plus usual activity. Exercise combined group sessions (interval indoor cycling and circuit training) with individual sessions at moderate-to-vigorous intensity, and adherence was tracked with sports watches and heart rate monitors. Changes from randomization to the end of treatment (weeks 0-52) were measured as: time to climb and descend an 11-step stairway twice, peak oxygen consumption normalized to fat-free mass, and isometric knee extensor peak torque.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    People randomized to exercise did a median 2.65 sessions per week (116 min per week at 79% of maximum heart rate), with no significant difference between the placebo and liraglutide groups.
  2. 2
    Compared with liraglutide alone, the combination shortened the stair-climb time by 1.2 s (95% CI 0.6-1.9), which is 8.6%, and raised peak oxygen consumption by 3.0 mL/min/kg fat-free mass (95% CI 0.5-5.5).
  3. 3
    Exercise alone gave similar benefits, while liraglutide alone did not improve physical fitness.
  4. 4
    Relative muscle strength (strength divided by body weight) changed by -7.8% with placebo, -0.4% with exercise, +1.0% with liraglutide and +3.3% with the combination. The authors attribute this to lower body weight and preserved absolute strength.

Límites e incertidumbre

  1. 1
    These are key secondary endpoints from a larger trial, so they carry more risk of chance findings than the primary outcome and were not powered for it.
  2. 2
    Only adults without diabetes who completed an 8-week diet were randomized, so results may not apply to people with diabetes or to those who could not lose weight on a diet.
  3. 3
    The abstract gives confidence intervals only for the combination-versus-liraglutide comparison, not for exercise alone or for strength.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

After weight loss, adding regular moderate-to-vigorous exercise appears to protect or improve fitness, whereas a weight-loss drug on its own did not. The exercise program was supervised and fairly structured, so a casual routine may not give the same effect. Medication choices belong with your clinician.

Tus datos

Useful personal measures are weekly exercise minutes and time at higher heart rate from a watch or chest strap, plus any VO2max estimate your device gives. Wearable VO2max is an estimate, so compare it only with itself, from the same device, over months, and alongside simple tests such as timed stair climbs done the same way each time.

Cómo interpretar la evidencia

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Obesity is associated with impaired physical fitness, including physical functional performance and cardiorespiratory fitness, which affect health-related quality of life and mortality.

Objective

We aimed to investigate the efficacy of a moderate-to-vigorous intensity exercise program and glucagon-like peptide-1 receptor agonist treatment alone or in combination during weight maintenance for physical fitness.

Methods

This is secondary analysis of a randomized controlled trial involving 193 adults with obesity (age 18-65 years, body mass index 32-43 kg/m^(2)) without diabetes mellitus who completed an 8-week low-calorie diet and were subsequently randomized (1:1:1:1 ratio) to: exercise plus placebo; glucagon-like peptide-1 receptor agonist liraglutide 3 mg once-daily plus usual activity; exercise plus liraglutide combined; or placebo plus usual activity. The exercise program was a combination of group sessions (interval-based indoor cycling followed by circuit training) and individual sessions of moderate-to-vigorous intensity, designed to meet the World Health Organization recommendations on physical activity for health. Exercise adherence was measured with sports watches and heart rate monitors. Key secondary endpoints related to physical fitness were changes from randomization to the end of treatment (weeks 0-52) in: (1) physical functional performance (time to ascend and descend an 11-step stairway twice); (2) cardiorespiratory fitness (peak oxygen consumption normalized to fat-free mass); and (3) muscle strength (isometric knee extensor peak torque).

Results

Participants randomized to exercise performed a median 2.65 session/week (116 min/week at 79% of maximum heart rate) with no significant difference between those who received placebo or liraglutide. Compared with liraglutide alone, the combined treatment decreased time to complete a stair climb test by 1.2 s [95% confidence interval 0.6-1.9] (corresponding to 8.6%) and improved peak oxygen consumption by 3.0 mL/min/kg fat-free mass [95% confidence interval 0.5-5.5]. Exercise alone led to similar benefits, whereas liraglutide alone did not improve physical fitness. Compared with placebo (- 7.8%), relative muscle strength (strength normalized to body weight) was higher with exercise (- 0.4%), liraglutide (+ 1.0%), and the combined treatment (+ 3.3%) because of lower weight and preserved absolute strength.

Conclusions

Structured exercise combined with glucagon-like peptide-1-based obesity pharmacotherapy led to clinically meaningful improvements in physical functional performance and cardiorespiratory fitness, in contrast to pharmacotherapy alone.

Clinical trial registration

EudraCT number, 2015-005585-32; ClinicalTrials.gov number, NCT04122716.

Fuentes y atribución

Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity.

Jensen SBK, Fiorenza M, Juhl CR, Sandsdal RM, Jensen E, Seier SS, Janus C, Jørgensen JR, Blond MB, Holst JJ, Stallknecht BM, Madsbad S, Bandholm T, Torekov SS.

Sports medicine (Auckland, N.Z.) · 2026-01-24

DOI: 10.1007/s40279-025-02386-0 ↗PubMed · 41579235 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis de ensayos

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Nutrición y metabolismo →